MORGAN STANLEY PLC/CALL/AMGEN/440/0.1/20.06.25 | Delayed Börse Stuttgart 09:28:58 07/06/2024 pm IST | ||
| 0.54 EUR | -5.26% |
|
| Current month | +1.89% | ||
| 1 month | +10.20% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 07/24/07 | 0.54 | -5.26% |
| 06/24/06 | 0.57 | -5.00% |
| 05/24/05 | 0.6 | +3.45% |
| 04/24/04 | 0.58 | +3.57% |
| 03/24/03 | 0.56 | +5.66% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 09:28 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME3CZC |
| ISIN | DE000ME3CZC2 |
| Date issued | 09/11/2023 |
| Strike | 440 $ |
| Maturity | 20/06/2025 (376 Days) |
| Parity | 10 : 1 |
| Emission price | 0.28 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.88 € |
|---|---|
| Lowest since issue | 0.25 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Warrants
- Warrant
